Alice Pons
Impact in
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Colorectal Cancer Treatments and Studies
- Immunology top 2%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 5
- Cancer Immunotherapy and Biomarkers 5
- CAR-T cell therapy research 3
-
- Immunotherapy and Immune Responses 3
- Co-authors
- Charles G. DrakeJanis M. TaubeIra WollnerWilliam H. SharfmanLieping ChenDrew M. PardollJulie R. BrahmerSuzanne L. Topalian
- Journals
- Journal of Clinical Oncology (2 papers)Scientific Reports (1 paper)European Urology Oncology (1 paper)Annals of Oncology (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesSpain
In The Last Decade
Alice Pons
8 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 72
- Oncology 2.4k
- Immunology 1.3k
- Pulmonary and Respiratory Medicine 668
- Cancer Research 225
- Pathology and Forensic Medicine 223
Countries citing papers authored by Alice Pons
This map shows the geographic impact of Alice Pons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alice Pons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alice Pons more than expected).
Fields of papers citing papers by Alice Pons
This network shows the impact of papers produced by Alice Pons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alice Pons. The network helps show where Alice Pons may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alice Pons, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2023 | 31 | |
| 3 | 2022 | 6 | |
| 4 | 2021 | 40 | |
| 5 | 2012 | 425 | |
| 6 | Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates Hit paper breakdown → | 2010 | 2331 |
| 7 | [The comparison of adverse reactions to anti-influenza vaccines of split-vision and surface antigens]. | 1996 | 3 |
| 8 | [Investigation of various risk factors associated with colorectal cancer by studying cases and controls]. | 1989 | 2 |
About Alice Pons
Alice Pons is a scholar working on Oncology, Immunology, Dermatology, Ophthalmology and Pulmonary and Respiratory Medicine, having authored 8 papers that have together received 2.8k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), CAR-T cell therapy research (3 papers), Immunotherapy and Immune Responses (3 papers), Renal cell carcinoma treatment (2 papers), Retinal and Optic Conditions (1 paper), Nonmelanoma Skin Cancer Studies (1 paper), Influenza Virus Research Studies (1 paper) and Hepatitis B Virus Studies (1 paper). The work is most often cited by research in Oncology (2.4k citations), Immunology (1.3k citations), Pulmonary and Respiratory Medicine (668 citations), Cancer Research (225 citations) and Pathology and Forensic Medicine (223 citations). Alice Pons has collaborated with scholars based in United States and Spain. Frequent co-authors include Charles G. Drake, Janis M. Taube, Ira Wollner, William H. Sharfman, Lieping Chen, Drew M. Pardoll, Julie R. Brahmer, Suzanne L. Topalian, Robert A. Anders and Israel Lowy. Their work appears in journals such as Journal of Clinical Oncology, Scientific Reports, European Urology Oncology, Annals of Oncology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.